Hong Kong, July 12, 2022, Menet, the healthcare information platform announced the annual ranking series of Chinese Pharmaceutical Industry in 2021. Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) continued to hold the award of “Top 100 Chinese Chemical Pharmaceutical Companies” in the year 2021. The Group has been the winner of this […]
TOKYO & HONG KONG, June 30, 2022 ‐ Lee’s Pharmaceutical Holdings Limited (SEHK stock code: 0950, Headquarters: Hongkong, Executive Managing Director: Lee lalertsuphakun Wanee, hereinafter “Lee’s Pharm”) and Solasia Pharma K.K. (TSE: 4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter “Solasia”) jointly announced today that Solasia and Lee’s Pharm have entered into a […]
Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) is pleased to announce that, on 31 May 2022, the Drug Registration Certificate for in-licensed product Teglutik® (Riluzole Oral Suspension) has been obtained from the China National Medical Products Administration (NMPA). Teglutik® has been approved to extend life or the time to mechanical ventilation for […]
Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) is pleased to announce that, the Drug Registration Certificate for in-licensed product Natulan® (Procarbazine Capsules) has been obtained from the China National Medical Products Administration (“NMPA”). Natulan® has been approved for use in combination with other anticancer drugs to treat Hodgkin’s Lymphoma (“HL”). ดาวน์โหลดข่าวฉบับเต็ม (PDF) […]
Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”) announced that, the registration of in-licensed product “Nitric Oxide for Inhalation” (INOmax®) was approved for commercialization by China National Medical Products Administration (NMPA). INOmax®, the first medicinal gas product approved in China, is an inhaled nitric oxide pharmaceutical for treating term and near-term neonates (>34weeks) with […]
Hong Kong, March 22, 2022, the Retail Sales Department of the Group Commercial Operations Centre, Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”) signed the Comprehensive Strategic Cooperation Agreement with Guangdong Rongtai Pharmaceutical Company Limited (“Rongtai Pharmaceutical”). ดาวน์โหลดข่าวฉบับเต็ม (PDF) ที่มา: Lee’s Pharmaceutical Holdings – News & Media
Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”) aims at expanding the distribution channels and offering wide array of health and pharmaceutical products to meet the variety of needs. The Group launched the flagship store on Ali’s and Jingdong’s e-commerce platforms in China on March 23, 2022. Dr. Li Xiaoyi, the founder and Ms. […]
Recently, the Anhui Provincial Department of Economy and Information Technology announced the list of “Anhui Provincial Role Model Enterprise in Consumer Products Industry” through online platform. Zhaoke Pharmaceutical (Hefei) Company Limited (“Zhaoke-Hefei”), the subsidiary of Lee’s Pharmaceutical Holdings Limited was one of the few pharmaceutical companies to receive this honour. ดาวน์โหลดข่าวฉบับเต็ม (PDF) ที่มา: Lee’s Pharmaceutical […]
Hong Kong, December 23, 2021, the “STEM Experience Program for Secondary Students—Kanya Lee Scholarship Recognition Ceremony” was successfully held in Cordis Hotel, Hong Kong. The founder and Non-Executive Director, Dr. Li Xiaoyi, the Chairman, Ms. Lee Siu Fong and the Managing Director, Ms. Leelalertsuphakun Wanee of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”) […]
Hong Kong, December 23, 2021, the “2020-2021 Top Brand List of Family Choice Pharmacy in China”, jointly organized by familydoctor.com.cn and Sinomonitor, was officially announced through online platform. Two of the signature products from Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”) are granted admission into the guidance list. The in-licensed product Ferplex® and […]
English 
Thai